IRIN examines whether poverty reduction schemes can help lower TB rate in developing countries

IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of [tuberculosis (TB)] in developing countries." The news service writes, "TB is a disease often associated with poverty because latent infections are more easily activated by malnutrition and lowered immune systems, and more quickly passed on in badly ventilated, overcrowded living conditions."

The news service quotes a number of TB experts speaking at a meeting hosted by the London School of Hygiene and Tropical Medicine on February 15; provides data from a study in Malawi presented at the meeting, which "showed clear health benefits from even very modest cash transfers to the most disadvantaged households"; and cites Brazil as a country that "has achieved a steady decrease in TB and has halved the death rate since 1990, despite not achieving the conventional benchmarks for a successful control program. "'Social protection issues are fundamental in TB control, and that is why TB control now has to go beyond working with national TB programs … they are too low in the hierarchical agenda of countries,' Mario Raviglione, [the head of the WHO Stop TB department,] told IRIN," the news service notes (2/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO reports alarming rise in tuberculosis cases in 2023